Section Arrow
TOVX.NYSE-M
- Theriva Biologics Inc
Quotes are at least 15-min delayed:2026/07/15 07:20 EDT
Pre Market
Last
 0.2325
-0.0076 (-3.17%)
Bid
0.23
Ask
0.235
High 0.2401 
Low 0.2286 
Volume 43.49K 
Regular Hours (Closed)
Last
 0.2401
+0.0061 (+2.61%)
Day High 
0.2472 
Prev. Close
0.234 
1-M High
0.31 
Volume 
982.66K 
Bid
0.23
Ask
0.235
Day Low
0.227 
Open
0.227 
1-M Low
0.2207 
Market Cap 
10.74M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 0.24 
20-SMA 0.25 
50-SMA 0.29 
52-W High 0.8632 
52-W Low 0.1628 
Exchange NYSE-M 
Valuation Estimation
EPS (Current/Estimated)
-0.58/-0.22
Enterprise Value
12.76M
Balance Sheet
Book Value Per Share
0.34
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
NXTCNextCure Inc6.58+4.4+201.83%-- 
Pre Market 5.08 -1.5 -22.80%
AEONAEON Biopharma0.357+0.0349+10.84%-- 
Pre Market 0.3088 -0.0482 -13.50%
GOSSGossamer Bio0.1401-0.004-2.78%-- 
Pre Market 0.1408 +0.0007 +0.50%
RXRXRecursion Pharmaceuticals3.34+0.04+1.21%-- 
Pre Market 3.37 +0.03 +0.90%
ENSCEnsysce Biosciences0.2925+0.017+6.17%-- 
Pre Market 0.275 -0.0175 -5.98%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. Product Candidates includes SYN-004 (ribaxamase) and SYN-020.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.